25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Theragen Etex Co.Ltd
Buy, Hold or Sell?

Let's analyze Theragen Etex Co.Ltd together

I guess you are interested in Theragen Etex Co.Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Theragen Etex Co.Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Theragen Etex Co.Ltd

I send you an email if I find something interesting about Theragen Etex Co.Ltd.

1. Quick Overview

1.1. Quick analysis of Theragen Etex Co.Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Theragen Etex Co.Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩5,668.78
Expected worth in 1 year
₩7,016.25
How sure are you?
62.5%

+ What do you gain per year?

Total Gains per Share
₩1,347.47
Return On Investment
39.8%

For what price can you sell your share?

Current Price per Share
₩3,385.00
Expected price per share
₩2,800 - ₩4,010
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Theragen Etex Co.Ltd (5 min.)




Live pricePrice per Share (EOD)
₩3,385.00

2.2. Growth of Theragen Etex Co.Ltd (5 min.)




Is Theragen Etex Co.Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$127m$99.6m$12.2m10.9%

How much money is Theragen Etex Co.Ltd making?

Current yearPrevious yearGrowGrow %
Making money$4.6m$747.3k$3.9m83.9%
Net Profit Margin10.9%2.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Theragen Etex Co.Ltd (5 min.)




2.4. Comparing to competitors in the Pharmaceuticals industry (5 min.)




  Industry Rankings (Pharmaceuticals)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Theragen Etex Co.Ltd?

Welcome investor! Theragen Etex Co.Ltd's management wants to use your money to grow the business. In return you get a share of Theragen Etex Co.Ltd.

First you should know what it really means to hold a share of Theragen Etex Co.Ltd. And how you can make/lose money.

Speculation

The Price per Share of Theragen Etex Co.Ltd is ₩3,385. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Theragen Etex Co.Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Theragen Etex Co.Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩5,668.78. Based on the TTM, the Book Value Change Per Share is ₩336.87 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-40.86 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Theragen Etex Co.Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.020.0%0.150.0%0.010.0%0.060.0%0.030.0%
Usd Book Value Change Per Share0.070.0%0.240.0%-0.030.0%0.090.0%0.050.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.070.0%0.240.0%-0.030.0%0.090.0%0.050.0%
Usd Price Per Share2.59-2.92-3.05-4.55-5.24-
Price to Earnings Ratio35.50-18.15-21.62-11.21-26.58-
Price-to-Total Gains Ratio38.66-9.58-72.97-105.17-108.41-
Price to Book Ratio0.65-0.86-0.98-1.11-2.04-
Price-to-Total Gains Ratio38.66-9.58-72.97-105.17-108.41-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.3695
Number of shares422
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.240.09
Usd Total Gains Per Share0.240.09
Gains per Quarter (422 shares)99.5138.35
Gains per Year (422 shares)398.04153.38
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103983880153143
207967860307296
30119411840460449
40159215820614602
50199019800767755
60238823780920908
7027862776010741061
8031843174012271214
9035823572013801367
10039803970015341520

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%9.03.00.075.0%11.09.00.055.0%22.015.03.055.0%26.015.05.056.5%
Book Value Change Per Share3.01.00.075.0%5.07.00.041.7%11.09.00.055.0%25.015.00.062.5%30.016.00.065.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.046.00.0%
Total Gains per Share3.01.00.075.0%5.07.00.041.7%11.09.00.055.0%25.015.00.062.5%30.016.00.065.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Theragen Etex Co.Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--95.587336.867-72%-40.856+143%129.807-26%76.795+24%
Book Value Per Share--5668.7784992.982+14%4446.879+27%6199.575-9%4505.117+26%
Current Ratio--1.3101.373-5%1.452-10%1.485-12%1.194+10%
Debt To Asset Ratio--0.3730.387-4%0.420-11%0.382-3%0.393-5%
Debt To Equity Ratio--0.6640.719-8%0.725-8%0.650+2%0.701-5%
Dividend Per Share----0%-0%-0%-0%
Eps--26.019207.695-87%12.570+107%91.530-72%46.406-44%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.925+8%
Market Cap103161598500.000-15%118259875405.000133622457325.000-11%139223403000.000-15%203343327935.000-42%230874977455.000-49%
Net Profit Margin--0.0130.109-88%0.022-41%0.062-79%0.032-59%
Operating Margin----0%0.029-100%-0.0080%-0.0060%
Operating Ratio--0.9911.340-26%1.188-17%0.950+4%1.042-5%
Pb Ratio0.597-9%0.6520.856-24%0.981-34%1.107-41%2.038-68%
Pe Ratio32.525-9%35.50318.153+96%21.616+64%11.210+217%26.579+34%
Price Per Share3385.000-9%3695.0004175.000-11%4350.000-15%6506.500-43%7491.875-51%
Price To Free Cash Flow Ratio----7.1570%1.656-100%5.191-100%-5.8050%
Price To Total Gains Ratio35.413-9%38.6569.579+304%72.969-47%105.173-63%108.412-64%
Quick Ratio---0.567-100%1.133-100%1.058-100%1.154-100%
Return On Assets--0.0030.027-89%0.004-34%0.013-78%0.007-58%
Return On Equity--0.0050.050-90%0.007-29%0.024-79%0.012-58%
Total Gains Per Share--95.587336.867-72%-40.856+143%129.807-26%76.795+24%
Usd Book Value--127001970.900111861600.974+14%99626835.635+27%136007676.528-7%97990872.457+30%
Usd Book Value Change Per Share--0.0670.236-72%-0.029+143%0.091-26%0.054+24%
Usd Book Value Per Share--3.9683.495+14%3.113+27%4.340-9%3.154+26%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0180.145-87%0.009+107%0.064-72%0.032-44%
Usd Free Cash Flow---325289.123-100%1159740.285-100%491162.942-100%-684495.5240%
Usd Market Cap72213118.950-15%82781912.78493535720.128-11%97456382.100-15%142340329.555-42%161612484.219-49%
Usd Price Per Share2.370-9%2.5872.923-11%3.045-15%4.555-43%5.244-51%
Usd Profit--582917.3004653148.341-87%747326.631-22%1997754.179-71%1012910.762-42%
Usd Revenue--44432896.20042340477.064+5%35557599.487+25%32179326.273+38%25711677.944+73%
Usd Total Gains Per Share--0.0670.236-72%-0.029+143%0.091-26%0.054+24%
 EOD+3 -4MRQTTM+10 -17YOY+16 -135Y+5 -2310Y+15 -12

3.3 Fundamental Score

Let's check the fundamental score of Theragen Etex Co.Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1532.525
Price to Book Ratio (EOD)Between0-10.597
Net Profit Margin (MRQ)Greater than00.013
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than11.310
Debt to Asset Ratio (MRQ)Less than10.373
Debt to Equity Ratio (MRQ)Less than10.664
Return on Equity (MRQ)Greater than0.150.005
Return on Assets (MRQ)Greater than0.050.003
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Theragen Etex Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.729
Ma 20Greater thanMa 503,354.500
Ma 50Greater thanMa 1003,439.000
Ma 100Greater thanMa 2003,606.800
OpenGreater thanClose3,405.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Theragen Etex Co.Ltd

Theragen Etex Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products. It offers drugs in the fields of circulatory, respiratory, digestive, antibiotics, antifungals, analgesic, endocrine and metabolic, hepatoprotective, psychotropic, urinary system, skeletal muscle, PMS, anthelmintic, nutrition, and others. The company was formerly known as Theragen Co., Ltd. and changed its name to Theragen Etex Co.,Ltd. in July 2010. Theragen Etex Co.,Ltd. was founded in 1987 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-11-18 17:55:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Theragen Etex Co.Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Theragen Etex Co.Ltd to the Pharmaceuticals industry mean.
  • A Net Profit Margin of 1.3% means that ₩0.01 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Theragen Etex Co.Ltd:

  • The MRQ is 1.3%. The company is making a profit. +1
  • The TTM is 10.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ1.3%TTM10.9%-9.5%
TTM10.9%YOY2.2%+8.7%
TTM10.9%5Y6.2%+4.7%
5Y6.2%10Y3.2%+3.0%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3%9.8%-8.5%
TTM10.9%9.5%+1.4%
YOY2.2%9.9%-7.7%
5Y6.2%12.9%-6.7%
10Y3.2%12.6%-9.4%
4.3.1.2. Return on Assets

Shows how efficient Theragen Etex Co.Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Theragen Etex Co.Ltd to the Pharmaceuticals industry mean.
  • 0.3% Return on Assets means that Theragen Etex Co.Ltd generated ₩0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Theragen Etex Co.Ltd:

  • The MRQ is 0.3%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 2.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.3%TTM2.7%-2.4%
TTM2.7%YOY0.4%+2.3%
TTM2.7%5Y1.3%+1.4%
5Y1.3%10Y0.7%+0.6%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3%3.6%-3.3%
TTM2.7%3.5%-0.8%
YOY0.4%5.3%-4.9%
5Y1.3%5.9%-4.6%
10Y0.7%4.9%-4.2%
4.3.1.3. Return on Equity

Shows how efficient Theragen Etex Co.Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Theragen Etex Co.Ltd to the Pharmaceuticals industry mean.
  • 0.5% Return on Equity means Theragen Etex Co.Ltd generated ₩0.01 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Theragen Etex Co.Ltd:

  • The MRQ is 0.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 5.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.5%TTM5.0%-4.5%
TTM5.0%YOY0.7%+4.3%
TTM5.0%5Y2.4%+2.6%
5Y2.4%10Y1.2%+1.2%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5%4.6%-4.1%
TTM5.0%4.6%+0.4%
YOY0.7%8.2%-7.5%
5Y2.4%9.1%-6.7%
10Y1.2%10.3%-9.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Theragen Etex Co.Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Theragen Etex Co.Ltd is operating .

  • Measures how much profit Theragen Etex Co.Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Theragen Etex Co.Ltd to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Theragen Etex Co.Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY2.9%-2.9%
TTM-5Y-0.8%+0.8%
5Y-0.8%10Y-0.6%-0.1%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.2%-13.2%
TTM-12.0%-12.0%
YOY2.9%12.4%-9.5%
5Y-0.8%8.6%-9.4%
10Y-0.6%12.1%-12.7%
4.3.2.2. Operating Ratio

Measures how efficient Theragen Etex Co.Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 0.99 means that the operating costs are ₩0.99 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Theragen Etex Co.Ltd:

  • The MRQ is 0.991. The company is less efficient in keeping operating costs low.
  • The TTM is 1.340. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.991TTM1.340-0.349
TTM1.340YOY1.188+0.152
TTM1.3405Y0.950+0.390
5Y0.95010Y1.042-0.092
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9911.225-0.234
TTM1.3401.220+0.120
YOY1.1881.311-0.123
5Y0.9501.249-0.299
10Y1.0421.240-0.198
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Theragen Etex Co.Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Theragen Etex Co.Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 1.31 means the company has ₩1.31 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Theragen Etex Co.Ltd:

  • The MRQ is 1.310. The company is just able to pay all its short-term debts.
  • The TTM is 1.373. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.310TTM1.373-0.064
TTM1.373YOY1.452-0.079
TTM1.3735Y1.485-0.112
5Y1.48510Y1.194+0.291
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3102.213-0.903
TTM1.3732.234-0.861
YOY1.4522.028-0.576
5Y1.4852.199-0.714
10Y1.1941.995-0.801
4.4.3.2. Quick Ratio

Measures if Theragen Etex Co.Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Theragen Etex Co.Ltd to the Pharmaceuticals industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Theragen Etex Co.Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.567-0.567
TTM0.567YOY1.133-0.566
TTM0.5675Y1.058-0.491
5Y1.05810Y1.154-0.096
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.926-0.926
TTM0.5670.973-0.406
YOY1.1331.515-0.382
5Y1.0581.591-0.533
10Y1.1541.399-0.245
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Theragen Etex Co.Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Theragen Etex Co.Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Theragen Etex Co.Ltd to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.37 means that Theragen Etex Co.Ltd assets are financed with 37.3% credit (debt) and the remaining percentage (100% - 37.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Theragen Etex Co.Ltd:

  • The MRQ is 0.373. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.387. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.373TTM0.387-0.015
TTM0.387YOY0.420-0.032
TTM0.3875Y0.382+0.005
5Y0.38210Y0.393-0.010
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3730.345+0.028
TTM0.3870.339+0.048
YOY0.4200.333+0.087
5Y0.3820.315+0.067
10Y0.3930.339+0.054
4.5.4.2. Debt to Equity Ratio

Measures if Theragen Etex Co.Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Theragen Etex Co.Ltd to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 66.4% means that company has ₩0.66 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Theragen Etex Co.Ltd:

  • The MRQ is 0.664. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.719. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.664TTM0.719-0.054
TTM0.719YOY0.725-0.006
TTM0.7195Y0.650+0.069
5Y0.65010Y0.701-0.051
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6640.547+0.117
TTM0.7190.547+0.172
YOY0.7250.499+0.226
5Y0.6500.476+0.174
10Y0.7010.548+0.153
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Theragen Etex Co.Ltd generates.

  • Above 15 is considered overpriced but always compare Theragen Etex Co.Ltd to the Pharmaceuticals industry mean.
  • A PE ratio of 35.50 means the investor is paying ₩35.50 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Theragen Etex Co.Ltd:

  • The EOD is 32.525. Based on the earnings, the company is overpriced. -1
  • The MRQ is 35.503. Based on the earnings, the company is overpriced. -1
  • The TTM is 18.153. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD32.525MRQ35.503-2.979
MRQ35.503TTM18.153+17.350
TTM18.153YOY21.616-3.463
TTM18.1535Y11.210+6.943
5Y11.21010Y26.579-15.368
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD32.52527.863+4.662
MRQ35.50329.844+5.659
TTM18.15327.532-9.379
YOY21.61623.102-1.486
5Y11.21027.577-16.367
10Y26.57929.248-2.669
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Theragen Etex Co.Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-7.157+7.157
TTM-7.157YOY1.656-8.813
TTM-7.1575Y5.191-12.348
5Y5.19110Y-5.805+10.996
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.531-29.531
TTM-7.15729.447-36.604
YOY1.65626.360-24.704
5Y5.19131.734-26.543
10Y-5.80534.357-40.162
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Theragen Etex Co.Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 0.65 means the investor is paying ₩0.65 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Theragen Etex Co.Ltd:

  • The EOD is 0.597. Based on the equity, the company is cheap. +2
  • The MRQ is 0.652. Based on the equity, the company is cheap. +2
  • The TTM is 0.856. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.597MRQ0.652-0.055
MRQ0.652TTM0.856-0.204
TTM0.856YOY0.981-0.125
TTM0.8565Y1.107-0.251
5Y1.10710Y2.038-0.931
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD0.5974.659-4.062
MRQ0.6523.381-2.729
TTM0.8563.209-2.353
YOY0.9812.597-1.616
5Y1.1073.278-2.171
10Y2.0384.179-2.141
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets289,137,091
Total Liabilities107,705,704
Total Stockholder Equity162,089,627
 As reported
Total Liabilities 107,705,704
Total Stockholder Equity+ 162,089,627
Total Assets = 289,137,091

Assets

Total Assets289,137,091
Total Current Assets126,605,756
Long-term Assets162,531,334
Total Current Assets
Total Current Assets  (as reported)126,605,756
Total Current Assets  (calculated)0
+/- 126,605,756
Long-term Assets
Long-term Assets  (as reported)162,531,334
Long-term Assets  (calculated)0
+/- 162,531,334

Liabilities & Shareholders' Equity

Total Current Liabilities96,676,257
Long-term Liabilities11,029,448
Total Stockholder Equity162,089,627
Total Current Liabilities
Total Current Liabilities  (as reported)96,676,257
Total Current Liabilities  (calculated)0
+/- 96,676,257
Long-term Liabilities
Long-term Liabilities  (as reported)11,029,448
Long-term Liabilities  (calculated)0
+/- 11,029,448
Total Stockholder Equity
Total Stockholder Equity (as reported)162,089,627
Total Stockholder Equity (calculated)0
+/- 162,089,627
Other
Common Stock Shares Outstanding 32,005
Net Invested Capital 162,089,627
Net Working Capital 29,929,499



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
116,280,609
118,122,989
119,320,398
120,960,408
122,746,433
118,550,957
120,540,307
125,691,164
127,132,841
131,952,045
133,285,075
137,926,051
138,076,121
134,761,205
137,178,571
140,956,496
140,820,019
142,948,632
144,134,846
145,421,347
146,261,922
152,237,764
158,209,184
174,677,523
174,812,919
180,595,432
177,410,514
241,498,170
254,326,896
333,500,184
525,363,307
534,885,513
447,415,805
388,980,122
360,233,171
350,073,168
279,663,437
242,065,509
246,976,680
246,553,217
236,676,993
250,827,963
228,574,054
243,135,219
278,074,152
289,137,091
289,137,091278,074,152243,135,219228,574,054250,827,963236,676,993246,553,217246,976,680242,065,509279,663,437350,073,168360,233,171388,980,122447,415,805534,885,513525,363,307333,500,184254,326,896241,498,170177,410,514180,595,432174,812,919174,677,523158,209,184152,237,764146,261,922145,421,347144,134,846142,948,632140,820,019140,956,496137,178,571134,761,205138,076,121137,926,051133,285,075131,952,045127,132,841125,691,164120,540,307118,550,957122,746,433120,960,408119,320,398118,122,989116,280,609
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
80,868,303
81,026,005
80,570,091
80,463,009
82,643,854
90,256,546
105,014,858
104,079,251
114,243,179
110,374,148
110,095,386
107,188,110
104,514,578
106,683,021
96,337,066
96,674,511
96,559,595
93,420,806
91,175,671
96,734,790
98,070,247
98,803,691
106,961,890
105,846,471
121,094,701
128,589,016
115,389,914
119,347,248
126,605,756
126,605,756119,347,248115,389,914128,589,016121,094,701105,846,471106,961,89098,803,69198,070,24796,734,79091,175,67193,420,80696,559,59596,674,51196,337,066106,683,021104,514,578107,188,110110,095,386110,374,148114,243,179104,079,251105,014,85890,256,54682,643,85480,463,00980,570,09181,026,00580,868,30300000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,742,166
3,336,447
5,286,402
4,929,996
7,028,307
5,708,111
14,831,273
12,011,940
10,206,650
9,035,655
9,810,215
11,136,790
12,094,588
12,355,492
14,248,208
10,520,437
9,004,547
5,208,188
29,929
61,078
72,992
74,917
60,315
94,484
89,368
29,663,564
21,732,850
21,278,481
0
021,278,48121,732,85029,663,56489,36894,48460,31574,91772,99261,07829,9295,208,1889,004,54710,520,43714,248,20812,355,49212,094,58811,136,7909,810,2159,035,65510,206,65012,011,94014,831,2735,708,1117,028,3074,929,9965,286,4023,336,4473,742,16600000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,408,696
1,575,092
2,140,092
3,104,092
2,077,954
1,965,954
1,419,534
1,173,534
1,062,963
1,097,963
0
0
0
1,096,506
1,518,135
1,593,599
1,030,000
1,317,188
1,397,188
1,303,188
2,530,188
2,676,939
3,100,000
3,714,186
3,220,000
2,613,314
1,547,500
1,027,500
0
01,027,5001,547,5002,613,3143,220,0003,714,1863,100,0002,676,9392,530,1881,303,1881,397,1881,317,1881,030,0001,593,5991,518,1351,096,5060001,097,9631,062,9631,173,5341,419,5341,965,9542,077,9543,104,0922,140,0921,575,0921,408,69600000000000000000
       Net Receivables 
43,197,077
44,984,700
42,950,799
45,921,768
48,539,251
46,156,537
44,907,254
53,139,401
51,126,624
51,496,785
52,755,252
50,218,326
52,664,652
51,376,965
51,138,506
53,272,485
52,456,150
53,205,223
54,897,527
53,044,406
51,894,823
2,228,967
61,349,794
68,253,689
66,893,908
78,988,808
75,403,648
75,796,296
71,042,192
67,878,158
70,227,468
59,613,772
61,341,863
64,568,798
66,483,219
58,669,562
61,778,211
58,917,880
60,147,377
58,964,437
56,259,493
59,531,595
64,152,913
64,389,184
63,116,568
0
063,116,56864,389,18464,152,91359,531,59556,259,49358,964,43760,147,37758,917,88061,778,21158,669,56266,483,21964,568,79861,341,86359,613,77270,227,46867,878,15871,042,19275,796,29675,403,64878,988,80866,893,90868,253,68961,349,7942,228,96751,894,82353,044,40654,897,52753,205,22352,456,15053,272,48551,138,50651,376,96552,664,65250,218,32652,755,25251,496,78551,126,62453,139,40144,907,25446,156,53748,539,25145,921,76842,950,79944,984,70043,197,077
       Other Current Assets 
1,359,459
1,794,900
1,187,814
1,884,174
1,804,831
1,544,915
2,122,791
1,860,269
2,439,908
1,278,302
2,343,867
12,827,444
1,926,730
1,019,858
1,465,954
891,830
954,026
1,198,439
1,202,827
804,579
1,027,555
51,202,946
998,631
1,592,611
1,572,348
1,427,763
1,973,595
1,591,712
2,008,757
1,899,736
1,721,991
900,074
829,553
745,679
949,529
926,327
1,439,767
1,379,475
1,286,661
5,000
5,000
1,603,356
0
-1
1,838,312
0
01,838,312-101,603,3565,0005,0001,286,6611,379,4751,439,767926,327949,529745,679829,553900,0741,721,9911,899,7362,008,7571,591,7121,973,5951,427,7631,572,3481,592,611998,63151,202,9461,027,555804,5791,202,8271,198,439954,026891,8301,465,9541,019,8581,926,73012,827,4442,343,8671,278,3022,439,9081,860,2692,122,7911,544,9151,804,8311,884,1741,187,8141,794,9001,359,459
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
139,591,327
130,830,523
129,733,262
99,985,037
127,745,305
158,726,903
162,531,334
162,531,334158,726,903127,745,30599,985,037129,733,262130,830,523139,591,327000000000000000000000000000000000000000
       Property Plant Equipment 
30,767,236
31,905,470
31,737,089
31,429,270
31,127,652
31,375,550
31,479,416
31,294,883
33,578,555
33,066,268
36,206,327
37,172,598
38,622,732
40,892,029
42,976,399
45,046,221
44,916,981
45,481,281
44,086,447
44,727,455
45,869,044
46,172,431
45,884,524
45,839,301
46,893,356
47,258,011
48,293,587
47,186,992
47,348,779
46,967,041
48,020,564
42,460,674
42,445,174
42,170,761
41,585,824
40,694,765
40,612,633
40,471,273
40,761,945
41,421,904
41,291,044
40,808,501
41,014,614
41,653,180
43,359,465
0
043,359,46541,653,18041,014,61440,808,50141,291,04441,421,90440,761,94540,471,27340,612,63340,694,76541,585,82442,170,76142,445,17442,460,67448,020,56446,967,04147,348,77947,186,99248,293,58747,258,01146,893,35645,839,30145,884,52446,172,43145,869,04444,727,45544,086,44745,481,28144,916,98145,046,22142,976,39940,892,02938,622,73237,172,59836,206,32733,066,26833,578,55531,294,88331,479,41631,375,55031,127,65231,429,27031,737,08931,905,47030,767,236
       Goodwill 
0
0
0
0
0
0
0
0
0
353,002
165,465
353,002
353,002
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,500,000
0
0
0
0
0
0
0
00000002,500,0000000000000000000000000000353,002353,002165,465353,002000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,308,693
9,945,411
13,614,354
13,455,177
16,610,849
6,167,879
10,012,444
9,921,321
13,666,622
13,320,783
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000013,320,78313,666,6229,921,32110,012,4446,167,87916,610,84913,455,17713,614,3549,945,41110,308,69300000000000000000
       Intangible Assets 
1,125,629
1,447,475
1,439,561
1,483,442
1,469,136
1,445,401
1,424,344
1,423,542
1,413,734
2,583,926
2,358,154
2,423,308
3,446,779
1,704,579
2,050,099
2,089,520
2,084,346
1,733,637
1,694,024
1,576,933
1,534,084
1,509,990
1,471,683
1,428,632
1,395,803
1,357,465
2,702,699
2,876,614
3,328,150
3,888,276
3,936,116
4,505,589
4,952,380
5,123,414
4,559,486
4,302,288
5,409,698
6,082,252
5,990,197
5,388,243
5,327,631
5,195,771
4,956,398
5,480,856
5,355,737
0
05,355,7375,480,8564,956,3985,195,7715,327,6315,388,2435,990,1976,082,2525,409,6984,302,2884,559,4865,123,4144,952,3804,505,5893,936,1163,888,2763,328,1502,876,6142,702,6991,357,4651,395,8031,428,6321,471,6831,509,9901,534,0841,576,9331,694,0241,733,6372,084,3462,089,5202,050,0991,704,5793,446,7792,423,3082,358,1542,583,9261,413,7341,423,5421,424,3441,445,4011,469,1361,483,4421,439,5611,447,4751,125,629
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
1
0
0
001-1000000000000000000000000000000000000000000
> Total Liabilities 
43,544,796
43,505,956
40,827,531
41,294,525
42,664,119
39,404,634
40,586,406
43,694,756
44,582,831
47,192,216
47,876,821
62,025,969
59,352,941
56,952,832
58,610,121
61,935,642
57,372,523
58,181,480
60,004,477
51,771,865
52,122,160
53,074,655
61,127,483
84,891,291
86,150,801
86,567,383
83,619,690
105,636,565
103,266,550
112,240,441
156,107,529
160,764,061
143,570,475
132,006,470
127,431,363
127,376,632
107,437,830
98,529,926
97,449,528
102,954,993
98,811,284
112,522,845
102,100,912
90,202,681
99,702,069
107,705,704
107,705,70499,702,06990,202,681102,100,912112,522,84598,811,284102,954,99397,449,52898,529,926107,437,830127,376,632127,431,363132,006,470143,570,475160,764,061156,107,529112,240,441103,266,550105,636,56583,619,69086,567,38386,150,80184,891,29161,127,48353,074,65552,122,16051,771,86560,004,47758,181,48057,372,52361,935,64258,610,12156,952,83259,352,94162,025,96947,876,82147,192,21644,582,83143,694,75640,586,40639,404,63442,664,11941,294,52540,827,53143,505,95643,544,796
   > Total Current Liabilities 
35,495,582
35,606,999
33,206,852
34,400,283
35,671,236
32,904,007
34,151,348
36,667,192
35,619,554
37,256,480
34,715,382
51,142,126
47,753,541
44,166,961
43,519,182
46,221,521
41,114,106
42,200,433
42,329,719
38,817,382
40,185,573
40,782,549
45,039,463
50,570,852
52,445,131
55,515,100
52,173,622
72,261,241
68,434,358
58,796,829
60,400,330
65,239,833
67,296,598
68,653,222
69,802,518
74,693,107
69,599,550
70,649,566
69,133,161
74,839,438
71,162,450
82,719,717
86,047,979
85,720,603
88,843,249
96,676,257
96,676,25788,843,24985,720,60386,047,97982,719,71771,162,45074,839,43869,133,16170,649,56669,599,55074,693,10769,802,51868,653,22267,296,59865,239,83360,400,33058,796,82968,434,35872,261,24152,173,62255,515,10052,445,13150,570,85245,039,46340,782,54940,185,57338,817,38242,329,71942,200,43341,114,10646,221,52143,519,18244,166,96147,753,54151,142,12634,715,38237,256,48035,619,55436,667,19234,151,34832,904,00735,671,23634,400,28333,206,85235,606,99935,495,582
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,503,811
475,800
5,217,680
2,436,900
314,567
3,576,636
2,025,537
2,025,620
5,025,620
5,025,620
38,476,003
36,304,926
30,262,075
29,158,305
27,017,975
27,202,434
29,897,473
31,541,474
30,785,771
26,457,643
25,485,765
26,976,575
26,907,555
25,632,365
33,639,889
0
0
0
0
000033,639,88925,632,36526,907,55526,976,57525,485,76526,457,64330,785,77131,541,47429,897,47327,202,43427,017,97529,158,30530,262,07536,304,92638,476,0035,025,6205,025,6202,025,6202,025,5373,576,636314,5672,436,9005,217,680475,80033,503,81100000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,503,811
475,800
5,217,680
2,436,900
314,567
3,576,636
2,025,537
2,025,620
5,025,620
5,025,620
0
0
0
0
0
0
0
0
0
0
0
0
27,632,005
26,275,565
31,379,559
33,344,783
34,314,135
34,213,007
0
034,213,00734,314,13533,344,78331,379,55926,275,56527,632,0050000000000005,025,6205,025,6202,025,6202,025,5373,576,636314,5672,436,9005,217,680475,80033,503,81100000000000000000
       Accounts payable 
16,354,162
16,675,365
16,251,109
17,772,229
17,377,266
17,125,051
16,787,023
18,854,189
18,330,333
18,106,942
18,631,452
14,624,223
0
16,260,737
15,806,536
15,658,429
15,463,522
15,513,525
0
15,507,934
16,781,735
17,399,939
17,203,766
16,524,096
0
20,301,773
17,277,934
14,939,479
14,949,760
14,396,801
15,890,689
13,565,277
15,402,486
13,148,112
13,940,720
15,009,793
15,961,122
17,868,049
16,954,316
18,772,779
18,033,122
19,802,320
20,058,455
20,111,581
24,566,418
0
024,566,41820,111,58120,058,45519,802,32018,033,12218,772,77916,954,31617,868,04915,961,12215,009,79313,940,72013,148,11215,402,48613,565,27715,890,68914,396,80114,949,76014,939,47917,277,93420,301,773016,524,09617,203,76617,399,93916,781,73515,507,934015,513,52515,463,52215,658,42915,806,53616,260,737014,624,22318,631,45218,106,94218,330,33318,854,18916,787,02317,125,05117,377,26617,772,22916,251,10916,675,36516,354,162
       Other Current Liabilities 
3,703,245
4,976,346
4,403,384
4,666,304
4,181,711
4,580,169
5,370,778
5,542,679
5,029,788
5,855,102
5,744,548
26,145,287
37,266,211
7,654,732
7,262,535
7,043,018
5,602,413
6,362,297
20,880,436
6,045,432
7,378,839
5,647,125
6,026,580
13,129,538
29,590,812
8,773,175
9,571,728
16,989,524
15,431,841
12,474,001
13,706,173
17,495,866
17,329,901
18,096,553
19,278,946
23,905,165
22,358,309
22,257,235
22,220,826
2,445,724
2,295,079
2,167,007
2,084,778
2,011,103
8,570,446
0
08,570,4462,011,1032,084,7782,167,0072,295,0792,445,72422,220,82622,257,23522,358,30923,905,16519,278,94618,096,55317,329,90117,495,86613,706,17312,474,00115,431,84116,989,5249,571,7288,773,17529,590,81213,129,5386,026,5805,647,1257,378,8396,045,43220,880,4366,362,2975,602,4137,043,0187,262,5357,654,73237,266,21126,145,2875,744,5485,855,1025,029,7885,542,6795,370,7784,580,1694,181,7114,666,3044,403,3844,976,3463,703,245
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,044,638
12,752,767
14,213,272
16,052,933
4,482,078
10,858,820
11,029,448
11,029,44810,858,8204,482,07816,052,93314,213,27212,752,76714,044,638000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,801,001
13,772,144
35,097,685
77,445,269
80,200,729
60,591,989
47,694,162
44,924,109
39,301,952
23,927,806
14,131,986
14,128,643
2,431,179
2,446,938
2,197,058
0
0
0
0
00002,197,0582,446,9382,431,17914,128,64314,131,98623,927,80639,301,95244,924,10947,694,16260,591,98980,200,72977,445,26935,097,68513,772,14413,801,001000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-33,503,811
-475,800
-5,217,680
-2,436,900
-314,567
-3,576,636
-2,025,537
-2,025,620
-5,025,620
-5,025,620
-38,476,003
-36,304,926
-30,262,075
-29,158,305
-27,017,975
-27,202,434
-29,897,473
-31,541,474
-30,785,771
-26,457,643
-25,485,765
-26,976,575
-24,925,323
-23,640,059
-32,170,070
1,411,170
1,617,847
1,354,159
0
01,354,1591,617,8471,411,170-32,170,070-23,640,059-24,925,323-26,976,575-25,485,765-26,457,643-30,785,771-31,541,474-29,897,473-27,202,434-27,017,975-29,158,305-30,262,075-36,304,926-38,476,003-5,025,620-5,025,620-2,025,620-2,025,537-3,576,636-314,567-2,436,900-5,217,680-475,800-33,503,81100000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
0
0
0
0
106,844
0
0106,8440000-1000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
507,287
475,394
578,394
590,830
589,687
744,042
977,807
1,060,220
1,067,823
0
1,469,620
1,964,865
2,243,183
2,320,880
2,645,481
3,135,794
3,365,934
2,838,573
2,824,995
3,952,929
3,882,751
3,773,419
0
0
0
0
0
0
0
00000003,773,4193,882,7513,952,9292,824,9952,838,5733,365,9343,135,7942,645,4812,320,8802,243,1831,964,8651,469,62001,067,8231,060,220977,807744,042589,687590,830578,394475,394507,28700000000000000000
> Total Stockholder Equity
67,323,682
69,149,490
72,985,916
74,019,999
74,383,207
73,272,990
74,056,120
76,153,190
76,675,136
76,996,287
77,553,726
68,824,943
70,314,900
70,928,422
71,735,118
72,104,812
76,616,856
77,987,373
77,347,601
86,925,163
87,419,631
90,777,778
88,038,301
80,918,031
79,751,836
85,018,042
84,714,226
135,861,605
151,060,346
221,259,743
369,255,779
374,121,452
303,845,330
256,973,651
232,801,808
222,696,536
172,225,607
143,535,583
149,527,152
143,598,224
137,865,710
138,305,118
110,535,677
135,701,179
160,257,779
162,089,627
162,089,627160,257,779135,701,179110,535,677138,305,118137,865,710143,598,224149,527,152143,535,583172,225,607222,696,536232,801,808256,973,651303,845,330374,121,452369,255,779221,259,743151,060,346135,861,60584,714,22685,018,04279,751,83680,918,03188,038,30190,777,77887,419,63186,925,16377,347,60177,987,37376,616,85672,104,81271,735,11870,928,42270,314,90068,824,94377,553,72676,996,28776,675,13676,153,19074,056,12073,272,99074,383,20774,019,99972,985,91669,149,49067,323,682
   Common Stock
13,687,548
13,787,548
13,887,548
13,887,548
13,887,548
13,887,548
13,887,548
13,887,548
13,887,548
13,887,548
13,907,548
13,907,548
13,917,548
13,917,548
13,917,548
13,917,548
14,417,548
14,549,694
14,549,694
15,177,666
15,306,603
15,379,103
15,395,603
15,457,572
15,467,572
15,472,572
15,472,572
15,514,979
15,514,979
16,061,274
16,202,218
16,207,218
16,222,218
16,232,218
16,237,218
16,237,218
16,237,218
16,237,218
16,237,218
16,237,218
16,237,218
16,237,218
0
0
0
0
000016,237,21816,237,21816,237,21816,237,21816,237,21816,237,21816,237,21816,237,21816,232,21816,222,21816,207,21816,202,21816,061,27415,514,97915,514,97915,472,57215,472,57215,467,57215,457,57215,395,60315,379,10315,306,60315,177,66614,549,69414,549,69414,417,54813,917,54813,917,54813,917,54813,917,54813,907,54813,907,54813,887,54813,887,54813,887,54813,887,54813,887,54813,887,54813,887,54813,887,54813,787,54813,687,548
   Retained Earnings 
2,210,161
0
0
1,069,436
1,140,227
1,257,020
0
1,494,621
0
0
1,915,062
1,924,039
0
2,084,275
0
2,305,689
0
-20,852,274
-21,632,511
1,822,256
-20,277,672
-18,904,520
-21,823,057
-29,226,083
-30,442,971
-25,527,928
-25,466,572
14,292,458
14,190,273
8,840,611
7,751,034
6,423,342
5,693,524
3,991,954
-162,958
-5,599,538
-626,112
1,493,418
6,274,148
4,519,851
5,869,125
6,321,805
9,858,395
30,109,003
31,456,201
0
031,456,20130,109,0039,858,3956,321,8055,869,1254,519,8516,274,1481,493,418-626,112-5,599,538-162,9583,991,9545,693,5246,423,3427,751,0348,840,61114,190,27314,292,458-25,466,572-25,527,928-30,442,971-29,226,083-21,823,057-18,904,520-20,277,6721,822,256-21,632,511-20,852,27402,305,68902,084,27501,924,0391,915,062001,494,62101,257,0201,140,2271,069,436002,210,161
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
95,643,562
95,685,265
110,088,480
112,448,544
110,604,440
110,783,871
110,911,748
110,961,477
110,354,909
110,354,909
110,433,650
110,536,191
110,887,213
110,887,213
110,887,213
0
0
0
0
0000110,887,213110,887,213110,887,213110,536,191110,433,650110,354,909110,354,909110,961,477110,911,748110,783,871110,604,440112,448,544110,088,48095,685,26595,643,562000000000000000000000000000
   Treasury Stock0000000000-1,768,665-2,452,353-2,452,353-1,768,665-1,768,665-1,798,591-1,798,591-1,798,591-1,798,5910000-1,798,591-1,798,591-2,452,353-1,768,665-2,452,353-2,452,353-1,768,665-1,768,665-2,452,353-2,452,353-2,452,353-2,452,353-2,452,353-2,452,353-2,452,353-2,452,353-2,452,353-2,452,353-2,452,353-2,452,353-2,452,353-3,830,353-3,830,353
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,767,334
2,907,799
2,078,508
2,645,687
1,346,324
1,283,869
509,846
397,121
187,536
-177,635
10,301,609
25,602,536
86,088,333
232,451,475
240,465,524
170,649,825
125,316,353
105,244,693
100,651,410
45,207,056
14,318,759
15,427,059
2,523,981
2,528,615
2,568,044
0
0
0
0
00002,568,0442,528,6152,523,98115,427,05914,318,75945,207,056100,651,410105,244,693125,316,353170,649,825240,465,524232,451,47586,088,33325,602,53610,301,609-177,635187,536397,121509,8461,283,8691,346,3242,645,6872,078,5082,907,7992,767,33400000000000000000



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue221,724,624
Cost of Revenue-119,070,314
Gross Profit102,654,310102,654,310
 
Operating Income (+$)
Gross Profit102,654,310
Operating Expense-209,847,713
Operating Income11,876,911-107,193,403
 
Operating Expense (+$)
Research Development4,672,479
Selling General Administrative64,123,552
Selling And Marketing Expenses0
Operating Expense209,847,71368,796,031
 
Net Interest Income (+$)
Interest Income794,097
Interest Expense-2,454,054
Other Finance Cost-443,060
Net Interest Income-1,216,896
 
Pretax Income (+$)
Operating Income11,876,911
Net Interest Income-1,216,896
Other Non-Operating Income Expenses0
Income Before Tax (EBT)33,022,88211,876,911
EBIT - interestExpense = -2,454,054
26,211,436
28,665,490
Interest Expense2,454,054
Earnings Before Interest and Taxes (EBIT)035,476,936
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax33,022,882
Tax Provision-3,068,593
Net Income From Continuing Ops29,954,29029,954,290
Net Income26,211,436
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net01,216,896
 

Technical Analysis of Theragen Etex Co.Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Theragen Etex Co.Ltd. The general trend of Theragen Etex Co.Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Theragen Etex Co.Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Theragen Etex Co.Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3,930 < 3,950 < 4,010.

The bearish price targets are: 3,095 > 2,800.

Tweet this
Theragen Etex Co.Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Theragen Etex Co.Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Theragen Etex Co.Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Theragen Etex Co.Ltd. The current macd is -24.76890484.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Theragen Etex Co.Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Theragen Etex Co.Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Theragen Etex Co.Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Theragen Etex Co.Ltd Daily Moving Average Convergence/Divergence (MACD) ChartTheragen Etex Co.Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Theragen Etex Co.Ltd. The current adx is 19.42.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Theragen Etex Co.Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Theragen Etex Co.Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Theragen Etex Co.Ltd. The current sar is 3,160.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Theragen Etex Co.Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Theragen Etex Co.Ltd. The current rsi is 49.73. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Theragen Etex Co.Ltd Daily Relative Strength Index (RSI) ChartTheragen Etex Co.Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Theragen Etex Co.Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Theragen Etex Co.Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Theragen Etex Co.Ltd Daily Stochastic Oscillator ChartTheragen Etex Co.Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Theragen Etex Co.Ltd. The current cci is 26.67.

Theragen Etex Co.Ltd Daily Commodity Channel Index (CCI) ChartTheragen Etex Co.Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Theragen Etex Co.Ltd. The current cmo is 5.65604262.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Theragen Etex Co.Ltd Daily Chande Momentum Oscillator (CMO) ChartTheragen Etex Co.Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Theragen Etex Co.Ltd. The current willr is -38.94736842.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Theragen Etex Co.Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Theragen Etex Co.Ltd Daily Williams %R ChartTheragen Etex Co.Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Theragen Etex Co.Ltd.

Theragen Etex Co.Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Theragen Etex Co.Ltd. The current atr is 119.98.

Theragen Etex Co.Ltd Daily Average True Range (ATR) ChartTheragen Etex Co.Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Theragen Etex Co.Ltd. The current obv is 36,255,009.

Theragen Etex Co.Ltd Daily On-Balance Volume (OBV) ChartTheragen Etex Co.Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Theragen Etex Co.Ltd. The current mfi is 38.06.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Theragen Etex Co.Ltd Daily Money Flow Index (MFI) ChartTheragen Etex Co.Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Theragen Etex Co.Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-17BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Theragen Etex Co.Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Theragen Etex Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.729
Ma 20Greater thanMa 503,354.500
Ma 50Greater thanMa 1003,439.000
Ma 100Greater thanMa 2003,606.800
OpenGreater thanClose3,405.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Theragen Etex Co.Ltd with someone you think should read this too:
  • Are you bullish or bearish on Theragen Etex Co.Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Theragen Etex Co.Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Theragen Etex Co.Ltd

I send you an email if I find something interesting about Theragen Etex Co.Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Theragen Etex Co.Ltd.

Receive notifications about Theragen Etex Co.Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.